One cause of fatty deposits in the hearts of diabetes patients settled

April 16, 2012
One cause of fatty deposits in the hearts of diabetes patients settled

The impaired substrate metabolism of diabetes patients is often expressed in an increase in fatty deposits in the cells of the heart muscle. Until now, the exact cause of this was unknown. Now, Austrian researchers at the MedUni Vienna in the Division of Endocrinology and Metabolism of MedUni Vienna in cooperation with the MR Centre of Excellence Vienna have shown that high blood sugar in combination with high levels of insulin – not an influx of fats – results in such deposits within a few hours. This could form the basis for even more heart-friendly treatments of diabetes patients, especially in the early stages of the disease.

In the study, published in the respected American journal Diabetes, 18 healthy women and men were given a large amount of grape sugar intravenously. “Within as few as six hours, the glucose already caused clearly visible fatty deposits in the heart. The injection of grape sugar, in combination with the release of insulin caused by the sugar, resulted in an overexertion of the heart’s metabolism“, said the study’s director, Michael Krebs of the University Department of Internal Medicine III. This proves that can occur without the direct influx of fats.

This was made visible for the first time using magnetic resonance imaging and spectroscopy. “This method makes it possible to observe the beating heart, not only as it works, but non-invasively and without ionizing radiation as it metabolizes energy“, explained Martin Krssak (University Department of Internal Medicine III).

In Austria alone, around 500,000 people are affected by diabetes. “The first diagnosis usually occurs by accident and on average five years too late“, said Krebs. Most patients with diabetes die of heart diseases. “Our data show that the foundation for damage can be laid early on, especially in patients with and hyperinsulinemia – an elevated insulin level – during prediabetes and early diabetes.“ Building on these new findings in relation to elevated blood sugar (hyperglycemia) and hyperinsulinemia, MedUni Vienna is conducting studies that should help to make the treatment of even more heart-friendly.

Explore further: High blood sugar lowers chances of surviving a heart attack

More information: “Short-Term Hyperinsulinemia and Hyperglycemia Increase Myocardial Lipid Content in Normal Subjects.” Y. Winhofer, et al. doi:10.2337/db11-1275

Related Stories

High blood sugar lowers chances of surviving a heart attack

March 26, 2012
Patients with high blood sugar run an increased risk of dying if they have a heart attack, and diabetics are less likely to survive in-hospital cardiac arrest than non-diabetics, reveals research at the Sahlgrenska Academy, ...

Well-controlled HIV doesn't affect heart metabolism, function

January 26, 2012
(Medical Xpress) -- People with HIV often develop blood sugar and lipid problems and other metabolic complications that increase the risk of heart disease. But new research at Washington University School of Medicine in St. ...

Dieting beats exercise for diabetes prevention, combination is best

August 30, 2011
Lifestyle changes that include dieting to lose weight and exercise can help prevent type 2 diabetes, but researchers were uncertain which element contributes more. A new study suggests that, in postmenopausal women at least, ...

Diabetics urged to steer clear of high fat diet

March 27, 2012
(Medical Xpress) -- The current thinking around following a high fat, low carb diet to encourage weight loss in diabetics with Type 2 Diabetes, may be misguided say researchers from Warwick Medical School.

New methods enable the early detection of Achilles tendon damage

January 31, 2012
Two biochemical methods, developed at the Centre of Excellence for High Field Magnetic Resonance at the MedUni Vienna by Vladimir Juras from the University Department of Radiodiagnostics, are enabling Achilles tendon damage ...

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.